These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7581971)

  • 21. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.
    Overgaard M; Pedersen SM
    Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macroprolactin detection by precipitation with protein A-sepharose: a rapid screening method compared with polyethylene glycol precipitation.
    Sapin R; Kertesz G
    Clin Chem; 2003 Mar; 49(3):502-5. PubMed ID: 12600967
    [No Abstract]   [Full Text] [Related]  

  • 23. Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody.
    Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
    Eur J Endocrinol; 1994 May; 130(5):438-45. PubMed ID: 8180669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia.
    Hattori N; Nakayama Y; Kitagawa K; Li T; Inagaki C
    Endocrinology; 2007 May; 148(5):2465-70. PubMed ID: 17303669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decision cut-off of the polyethylene glycol precipitation technique in screening for macroprolactinemia on Immulite 2000.
    Rivero A; Alonso E; Grijalba A
    Clin Chem Lab Med; 2004 May; 42(5):566-8. PubMed ID: 15202797
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunological aspects of human growth hormone and prolactin.
    Hattori N; Inagaki C
    Domest Anim Endocrinol; 1998 Sep; 15(5):371-5. PubMed ID: 9785041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin.
    Fahie-Wilson MN
    Clin Chem; 2000 Dec; 46(12):2022-3. PubMed ID: 11106347
    [No Abstract]   [Full Text] [Related]  

  • 28. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
    Olukoga AO; Kane JW
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
    Leaños A; Pascoe D; Fraga A; Blanco-Favela F
    Lupus; 1998; 7(6):398-403. PubMed ID: 9736323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of macroprolactinaemia.
    Hattori N; Adachi T; Ishihara T; Shimatsu A
    Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.
    Fahie-Wilson M; Bieglmayer C; Kratzsch J; Nusbaumer C; Roth HJ; Zaninotto M; Plebani M; Hubbuch A; Schneider E
    Clin Lab; 2007; 53(5-6):301-7. PubMed ID: 17605405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus.
    Blanco-Favela F; Chavez-Rueda K; Leaños-Miranda A
    Lupus; 2001; 10(10):757-61. PubMed ID: 11721703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should macroprolactin be measured in all hyperprolactinaemic sera?
    McKenna TJ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia].
    Leaños Miranda L; Bustos López HH; Fraga Mouret A; Blanco Favela F; Dalila Pascoe Lira ME; Dalila Pascoe Lira C
    Ginecol Obstet Mex; 1998 May; 66():179-86. PubMed ID: 9646575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia.
    Hattori N; Ishihara T; Ikekubo K; Moridera K; Hino M; Kurahachi H
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1226-9. PubMed ID: 1430082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macroprolactinemia: the consequences of a laboratory pitfall.
    Toldy E; Löcsei Z; Szabolcs I; Góth MI; Kneffel P; Szöke D; Kovács GL
    Endocrine; 2003 Dec; 22(3):267-73. PubMed ID: 14709800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
    Hattori N; Inagaki C
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3107-10. PubMed ID: 9284753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
    Jeske W; Zgliczynski W; Zdunowski P
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1909-10; author reply 1910. PubMed ID: 11932344
    [No Abstract]   [Full Text] [Related]  

  • 40. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol.
    Fahie-Wilson MN; Soule SG
    Ann Clin Biochem; 1997 May; 34 ( Pt 3)():252-8. PubMed ID: 9158821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.